Obstetrics/Gynecology
RSSArticles
-
Full January 15, 2008 Issue in PDF
-
Ciclesonide Nasal Spray (Omnaris™)
The FDA has approved a non-halogenated nasal steroid for use in pediatric patients aged 6 to 12 years and adults. Ciclesonide is a prodrug that was previously approved for adults and adolescents but was not marketed. It's to be marketed by Nycomed US Inc. as Omnaris. -
Duration of Immunity to Common Viral andVaccine Antigens
Serum analysis of 45 subjects for antibodies and humoral immunity over a median of 15 years showed antiviral responses ranging from 11-19 years for tetanus-diphtheria, 50 years for varicella-zoster, and up to 200 years for measles and mumps. -
Pharmacology Watch
FDA warnings for existing drugs dominate pharmaceutical news this month. -
ECG Review: Atypical Chest Pain and an Abnormal ECG
12-lead ECG obtained from a 50-year old African American man with hypertension and chest pain. -
Clinical Briefs by Louis Kuritzky, MD
-
Cereals and the Risk for Heart Failure:Is There a Link?
When whole grain cereal (WGC) is consumed regularly, there is a lower risk of developing heart failure (HF). This association is likely to be linked to the beneficial effects of WGC on risk factors (ie, hypertension, obesity, hyperlipidemia) rather than HF itself. -
A Simple Screen for Cancer?
An elevated white blood cell count is a risk factor for several cancers in women. -
Full January 2008 Issue in PDF
-
Clinical Briefs in Primary Care supplement